BRIACELL THERAPEUTICS CORP's ticker is and the CUSIP is 10778Y952. A total of 3 filers reported holding BRIACELL THERAPEUTICS CORP in Q1 2023. The put-call ratio across all filers is - and the average weighting 0.7%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $1 | 0.0% | 300 | +50.0% | 0.00% | – |
| Q1 2023 | $1 | -85.7% | 200 | -88.9% | 0.00% | – |
| Q4 2022 | $7 | -100.0% | 1,800 | -78.8% | 0.00% | – |
| Q3 2022 | $47,000 | +95.8% | 8,500 | +102.4% | 0.00% | – |
| Q2 2022 | $24,000 | -97.4% | 4,200 | -95.4% | 0.00% | -100.0% |
| Q1 2022 | $917,000 | +1268.7% | 90,500 | +1003.7% | 0.00% | – |
| Q4 2021 | $67,000 | – | 8,200 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SABBY MANAGEMENT, LLC | 3,815 | $1,667,155 | 1.46% |
| SIMPLEX TRADING, LLC | 1,800 | $7 | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |